What is the likely diagnosis of a 3mm nodule, previously considered stable, located in the fat anterior to the psoas muscle, caudal to the lower pole of the left kidney, in a patient with a history of partial nephrectomy for chromophobe renal cell carcinoma (RCC)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for the 3mm Nodular Finding

  • Single most likely diagnosis:
    • Benign lymph node: The fact that the 3mm nodular finding has been present since 1 month after the partial nephrectomy and has not changed significantly in size over 3 years suggests a benign nature. The "maturation" over time, with increased visibility due to advancements in CT imaging (thinner slice thickness and higher resolution), further supports this diagnosis. Lymph nodes can be found in various locations, including along the psoas muscle, and their presence in the fat anterior to the psoas, caudal to the lower pole of the left kidney, although less common, does not rule out a benign lymph node.
  • Other Likely diagnoses:
    • Fibrotic or inflammatory change: Given the patient's surgical history, it's possible that the 3mm nodular finding represents a fibrotic or inflammatory change rather than a lymph node or a metastatic deposit. However, the description provided leans more towards a discrete nodular structure, which is less typical for fibrosis or inflammation.
    • Vascular structure or variant: It could potentially represent a small vascular structure or an anatomical variant, though this would be less likely given the description as a nodular finding.
  • Do Not Miss (ddxs that may not be likely, but would be deadly if missed.):
    • Metastatic disease: Although the stability in size over 3 years and the context of the finding suggest a low likelihood, metastatic disease from the chromophobe RCC cannot be entirely ruled out without further investigation. The location, while not typical for the primary lymphatic drainage of the kidney, does not exclude the possibility of metastasis.
    • Other malignancies: Rarely, a new primary malignancy could present as a small nodular finding. Given the patient's history of RCC, vigilance for other malignancies is warranted.
  • Rare diagnoses:
    • Accessory spleen: Although extremely rare and usually associated with the spleen or areas where splenic tissue is commonly found, an accessory spleen could theoretically present as a small nodular mass. However, this location and the patient's history make it a highly unlikely diagnosis.
    • Other rare benign tumors: Such as a schwannoma, neurofibroma, or other soft tissue tumors, which could present as small nodular findings but are less likely given the clinical context.

The location of the 3mm nodular finding, while not the most common site for lymph nodes involved in the lymphatic drainage of the kidney, does not exclude the possibility of it being a benign lymph node. The lymphatic drainage of the kidney is complex and involves nodes along the renal vessels, in the paraaortic and paracaval regions, and less commonly, nodes in the retroperitoneal fat. The stability of the finding over time and its characteristics on imaging suggest a benign nature, but given the patient's history of cancer, careful monitoring and consideration of the differential diagnoses are essential.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.